• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.

作者信息

de Boer Nanne K H

机构信息

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands.

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, AG&M Research Institute, Amsterdam, the Netherlands.

出版信息

Gastroenterology. 2019 Jan;156(1):11-14. doi: 10.1053/j.gastro.2018.11.039. Epub 2018 Nov 22.

DOI:10.1053/j.gastro.2018.11.039
PMID:30472233
Abstract
摘要

相似文献

1
Thiopurine Therapy in Inflammatory Bowel Diseases: Making New Friends Should Not Mean Losing Old Ones.炎症性肠病中的硫嘌呤类药物治疗：结交新朋友不应意味着失去老朋友。
Gastroenterology. 2019 Jan;156(1):11-14. doi: 10.1053/j.gastro.2018.11.039. Epub 2018 Nov 22.
2
Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease.硫嘌呤甲基转移酶基因型筛查在即将开始使用硫唑嘌呤治疗炎症性肠病患者中的成本效益分析
Aliment Pharmacol Ther. 2004 Sep 15;20(6):593-9. doi: 10.1111/j.1365-2036.2004.02124.x.
3
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.硫嘌呤甲基转移酶活性联合6-硫鸟嘌呤代谢物水平可预测炎症性肠病患者对硫嘌呤类药物的临床反应。
Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4.
4
Addition of Allopurinol for Altering Thiopurine Metabolism to Optimize Therapy in Patients with Inflammatory Bowel Disease.加用别嘌醇改变巯嘌呤代谢以优化炎症性肠病患者的治疗。
Pharmacotherapy. 2018 Feb;38(2):259-270. doi: 10.1002/phar.2067. Epub 2018 Jan 10.
5
Does lymphopenia or macrocytosis reflect 6-thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine?淋巴细胞减少或大细胞增多是否反映了接受硫唑嘌呤或6-巯基嘌呤治疗的炎症性肠病患者的6-硫鸟嘌呤水平？
Intern Med J. 2016 Apr;46(4):465-9. doi: 10.1111/imj.12915.
6
Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?在开始使用硫嘌呤甲基转移酶治疗炎症性肠病患者之前，是否应该测量硫嘌呤甲基转移酶基因型和表型？
Ther Drug Monit. 2012 Dec;34(6):695-701. doi: 10.1097/FTD.0b013e3182731925.
7
Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use.别嘌醇增强硫嘌呤类药物治疗炎症性肠病的效果：安全性考量及使用指南
J Clin Pharm Ther. 2014 Apr;39(2):107-11. doi: 10.1111/jcpt.12125. Epub 2014 Jan 20.
8
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease.在一大群炎症性肠病患者中导致治疗方案调整的不良事件。
Aliment Pharmacol Ther. 2006 Jul 15;24(2):331-42. doi: 10.1111/j.1365-2036.2006.02977.x.
9
Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.在临床实践中使用硫嘌呤检测治疗炎症性肠病：对专家的全球调查。
Inflamm Bowel Dis. 2011 Dec;17(12):2480-7. doi: 10.1002/ibd.21662. Epub 2011 Feb 23.
10
Thiopurine therapy in inflammatory bowel disease.炎症性肠病的硫嘌呤治疗。
Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59.

引用本文的文献

1
Examination of the TPMT and NUDT15*3 Variants to Predict the Response to Thiopurines in an Italian Cohort of Patients with Inflammatory Bowel Disease.检测TPMT和NUDT15*3变体以预测意大利炎症性肠病患者队列对硫嘌呤类药物的反应。
Int J Mol Sci. 2025 Aug 14;26(16):7860. doi: 10.3390/ijms26167860.
2
and genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience.硫嘌呤类药物治疗的基因分型、TPMT酶活性及代谢物测定：参考实验室经验
Pharmacogenomics. 2024;25(16-18):679-688. doi: 10.1080/14622416.2025.2463866. Epub 2025 Feb 16.
3
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.
沙特儿童和青少年炎症性肠病诊断与管理共识指南。
Saudi J Gastroenterol. 2025 May 1;31(3):107-136. doi: 10.4103/sjg.sjg_171_24. Epub 2024 Aug 30.
4
Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency.硫鸟嘌呤给药对患有硫嘌呤甲基转移酶缺乏症的炎症性肠病患者的影响。
Metabolites. 2023 Oct 6;13(10):1054. doi: 10.3390/metabo13101054.
5
HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44 Natural Killer Cells in Ulcerative Colitis.上皮细胞上的 HLA-DP 使 NKp44 自然杀伤细胞在溃疡性结肠炎中引发组织损伤。
Gastroenterology. 2023 Oct;165(4):946-962.e13. doi: 10.1053/j.gastro.2023.06.034. Epub 2023 Jul 15.
6
Development and validation of a novel HPLC-UV method for simultaneous determination of azathioprine metabolites in human red blood cells.一种同时测定人红细胞中硫唑嘌呤代谢物的新型高效液相色谱-紫外检测法的开发与验证
Heliyon. 2023 Feb 21;9(3):e13870. doi: 10.1016/j.heliyon.2023.e13870. eCollection 2023 Mar.
7
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.巯嘌呤治疗溃疡性结肠炎：一项随机安慰剂对照试验。
J Crohns Colitis. 2023 Jul 5;17(7):1055-1065. doi: 10.1093/ecco-jcc/jjad022.
8
Budesonide with Low-Dose 6-Mercaptopurine as a Possible New Treatment for IgG4-Related Sclerosing Cholangitis and Systemic IgG4-Related Disease: A Case Report.布地奈德联合低剂量巯嘌呤治疗 IgG4 相关硬化性胆管炎和系统性 IgG4 相关疾病：一例报告
Am J Case Rep. 2022 Dec 8;23:e938272. doi: 10.12659/AJCR.938272.
9
6-Thioguanosine Monophosphate Prodrugs Display Enhanced Performance against Thiopurine-Resistant Leukemia and Breast Cancer Cells.6-硫代鸟苷单磷酸前药对巯基嘌呤耐药白血病和乳腺癌细胞显示出增强的疗效。
J Med Chem. 2022 Nov 24;65(22):15165-15173. doi: 10.1021/acs.jmedchem.2c01010. Epub 2022 Nov 14.
10
A report on the potential of Rac1/pSTAT3 protein levels in T lymphocytes to assess the pharmacodynamic effect of thiopurine therapy in Inflammatory Bowel Disease patients.Rac1/pSTAT3 蛋白水平在 T 淋巴细胞中评估巯嘌呤治疗炎症性肠病患者药效学效应的潜力报告。
Sci Rep. 2022 Sep 22;12(1):15806. doi: 10.1038/s41598-022-20197-5.